Researchers have been excited about Retatrutide , a innovative dual treatment showing promising outcomes in initial trials for size reduction . It acts by targeting two pathways : GLP-1 and GIP, which , when activated , help regulate hunger and boost energy expenditure . Early observations demonstrate noteworthy size loss and possible benefits for